News & Updates

The latest developments across the GLP-1 landscape, from new drug approvals and clinical research to pricing changes and policy shifts. Stay informed on the updates that affect Ozempic, Wegovy, Mounjaro, and the wider category.

News & Updates

GLP-1s and Breast Cancer: 5 New Research Findings

Emerging research is revealing important connections between GLP-1 medications and breast cancer, from potential protective effects to questions still being studied. If you are taking or considering semaglutide or tirzepatide, here is what the latest science says and what to discuss with your doctor.

News & Updates

GLP-1 Compounding: What Patients Need to Know

Compounded semaglutide and tirzepatide have helped millions of patients access GLP-1 medications at lower prices. But regulatory pressures are reshaping this market fast. Here's what you need to understand to protect your access and your wallet.

News & Updates

Generic Semaglutide: What Celon's Study Means for You

A Polish pharmaceutical company called Celon Pharma released early study data showing its generic semaglutide performs comparably to Ozempic. For patients paying out of pocket for GLP-1 medications, this development could eventually reshape the cost landscape significantly.

News & Updates

GLP-1 Self-Medication Risks You Need to Know

A Brazilian university study on GLP-1 self-medication reveals concerning patterns among adults using semaglutide and liraglutide for weight loss without a prescription. The findings raise important questions about safety, dosing, and what happens when these powerful medications are used outside a clinical setting. Here's what every GLP-1 patient needs to know.

News & Updates

Wegovy Pill: Novo's Lowest Dose Study Explained

Novo Nordisk has launched a new study to find the lowest effective dose for an oral version of Wegovy (semaglutide). This research could shape how millions of people access weight loss medication in pill form. Here's what patients need to know right now.

News & Updates

Online GLP-1 Prescriptions: What the Data Reveals

A new secret shopper study found that GLP-1 medications like semaglutide and tirzepatide are widely available through online platforms, often with minimal clinician involvement. For patients considering telehealth as a path to treatment, this raises real questions about safety, quality of care, and how to choose a trustworthy provider. Here's what the research found and what you should know before you fill out that intake form.

News & Updates

Needles Are Mainstream: GLP-1s, Botox & Peptides

From GLP-1 weight loss medications to Botox and peptide therapies, injectable treatments have gone mainstream. This guide helps GLP-1 patients understand how these treatments differ, what questions to ask providers, and how to avoid costly mistakes in a crowded market.

News & Updates

HumeCare Oral GLP-1: What You Need to Know

Oral GLP-1 medications are gaining traction as an alternative to weekly injections, and HumeCare is one of the newer players in this space. This review breaks down what HumeCare's oral GLP-1 program offers, what the science actually supports, and what questions to ask before you sign up.